Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
Cancers|August 29, 2024
Pathological Features Associated with Lymph Node Disease in Patients with Appendiceal Neuroendocrine TumorsSalvador Rodriguez Franco, Sumaya Abdul Ghaffar, Ying Jin, et al.
Annals of Surgery|June 10, 2010
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysisMechteld C De Jong, Michael B Farnell, Guido Sclabas, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2011
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experiencePeter J Kneuertz, Steven C Cunningham, John L Cameron, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trialJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Gastroenterology|May 28, 2018
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term SurveillanceMarcia Irene Canto, Jose Alejandro Almario, Richard D Schulick, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Annals of Surgery|July 18, 2020
Global Survey on Pancreatic Surgery During the COVID-19 PandemicAtsushi Oba, Thomas F Stoop, Matthias Löhr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesionsSteven C Cunningham, Farin Kamangar, Min P Kim, et al.
Pageof 30